コロンビア特別区における鎌状赤血球症の臨床試験
コロンビア特別区内の拠点で、鎌状赤血球症に関する10件の研究が参加者を募集しています。
コロンビア特別区内の都市
公式研究テキスト（英語）
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Childrens National Hospital, Washington D.C.
被験者募集中第3相
12歳〜100歳 · 全性別 · 2026/09/28更新 · NCT06439082A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Childrens National Medical Ctr, Washington D.C.
- MedStar Hlth Res Institute, Washington D.C.
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/17更新 · NCT06612268ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Georgetown University, Washington D.C.
- Children's National Hemophilia Center, Washington D.C.
被験者募集中観察研究
全年齢 · 全性別 · 2026/08/17更新 · NCT04398628Cooperative Assessment of Late Effects for SCD Curative Therapies
- Children's National Medical Center, Washington D.C.
被験者募集中観察研究
4歳〜65歳 · 全性別 · 2026/07/27更新 · NCT05153967Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Children's National Hospital (MRD-HCT), Washington D.C.
被験者募集中観察研究
3歳〜20歳 · 全性別 · 2026/06/04更新 · NCT06941389Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
- Children's National Hospital, Washington D.C.
被験者募集中第2相
4歳〜21歳 · 全性別 · 2026/04/13更新 · NCT06635902Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Children's National Health System, Washington D.C.
被験者募集中第2相
2歳〜25歳 · 全性別 · 2026/03/10更新 · NCT03587272Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
- Children's National Hospital, Washington D.C.
被験者募集中第2相
2歳〜25歳 · 全性別 · 2025/09/26更新 · NCT06358638Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
- Children's National Hospital, Washington D.C.
被験者募集中
7歳〜16歳 · 全性別 · 2025/02/13更新 · NCT06770010Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
- Children's National Hospital, Washington D.C.
被験者募集中
8歳〜16歳 · 全性別 · 2025/01/10更新 · NCT05099874ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。